Vir Biotechnology, Inc. (VIR) stock analysis

VIR · Vir Biotechnology, Inc.

Latest recorded price: USD 9.58

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth -65.1%, free cash flow margin -578.5%, ROIC -121.9%. The model flags 3 risk signals for this company (2 high severity).

Similar companies in Healthcare